Cancer Research UK partners with The Mark Foundation for Cancer Research to pave way for personalised immunotherapy treatments

The MATCHMAKERS project uses immunology, engineering, and AI to decipher how T-cell receptors pair with antigens.

The team’s approach to optimizing immunotherapy for cancer and many other diseases is exemplary of the type of interdisciplinary research The Mark Foundation prioritizes supporting.

In the tapestry of global health challenges, cancer stands out as the defining thread of our time.

Now, more than ever, we need to build on the success of the previous decades of cancer discoveries and go faster and further with the impact we have on people with cancer.

We are incredibly grateful to the Mark Foundation for Cancer Research for their continued partnership with Cancer Grand Challenges. This kind of partnership means that we can ask more questions that no one team or institution can tackle alone. Questions that if answered, could lead to a step-change in how we understand and treat cancer.